| CAP N= 57 | HAP N= 57 | VAP N= 61 | Over-all P | P(CAP versus VAP) |
---|---|---|---|---|---|
Age | 61.8 ± 18.7 | 64.6 ± 15.8 | 60.7 ± 16.2 | n.s. | n.s. |
Male | 35 (61.4%) | 38 (66.7%) | 35 (57.4%) | n.s. | n.s. |
APACHE II score | 26.2 ± 7.4 | 25.2 ± 9.4 | 20.1 ± 8.5 | < 0.001 | < 0.001 |
SOFA score | 7.6 ± 3.5 | 6.9 ± 3.7 | 6 ± 3.5 | 0.044 | 0.005 |
On antibiotics | 57 (100.0%) | 55 (96.5%) | 58 (95.1%) | n.s. | n.s. |
Coexisting diseases | Â | Â | Â | ||
Diabetes mellitus | 14 (24.6%) | 11 (19.3%) | 12 (19.7%) | n.s. | n.s. |
Cardiovascular disease | 28 (49.1%) | 24 (42.1%) | 16 (26.2%) | 0.032 | 0.010 |
Hypertension | 3 (5.3%) | 3 (5.3%) | 5 (8.2%) | n.s. | n.s. |
Malignancies | 14 (24.6%) | 20 (35.1%) | 11 (18.0)% | n.s. | n.s. |
COPD | 13 (22.8%) | 5 (8.8%) | 10 (16.4%) | n.s. | n.s. |
Liver cirrhosis | 4 (7.0%) | 1 (1.8%) | 1 (1.6%) | n.s. | n.s. |
Chronic renal failure | 2 (3.5%) | 4 (7.0%) | 3 (4.9%) | n.s. | n.s. |
HIV/AIDS | 1 (1.8%) | 2 (3.5%) | 1 (1.6%) | n.s. | n.s. |